Q97912951

Summary

Q97912951 is a committee group motion^[1].

Key Facts

• Q97912951 authored Kerstin Heinemann^[2].
• Q97912951 authored Marita Aronson^[3].
• Q97912951 authored Harald Nordlund^[4].
• Q97912951 authored Mia Franzén^[5].
• Q97912951 authored Gabriel Romanus^[6].
• Q97912951 authored Linnéa Darell^[7].
• Q97912951's instance of is recorded as committee group motion^[8].
• Q97912951's part of the series is recorded as motions of the 2004-2005 legislative session of the Riksdag^[9].
• Q97912951's language of work or name is recorded as Swedish^[10].
• Q97912951 was released on +2005-04-06T00:00:00Z^[11].
• Q97912951's main subject is drug^[12].
• Q97912951's work available at URL is recorded as http://data.riksdagen.se/dokument/GS02So29^[13].
• Q97912951's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GS02So29^[14].
• Q97912951's applies to jurisdiction is recorded as Sweden^[15].
• Q97912951's legal citation of this text is recorded as Mot. 2004/05:So29^[16].
• Q97912951's title is recorded as med anledning av prop. 2004/05:127 Vissa lagändringar beträffande hälsofarliga varor och narkotikaprekursorer^[17].
• Q97912951's has immediate cause is recorded as Q98138511^[18].
• Q97912951's cites work is recorded as Q98138511^[19].
• Q97912951's maintained by WikiProject is recorded as Project Riksdagen's documents^[20].
• Q97912951's copyright status is recorded as public domain^[21].
• Q97912951's legislative committee is recorded as Committee on Health and Welfare^[22].

Body

Definition and Type

Q97912951's instance of is recorded as committee group motion^[8].